Focused Sessions – Block III of V

Concurrent Events

• 09:10 AM - 09:50 AM

  Cybersecurity, Privacy and Resilience in AI Age | Pitfalls to Avoid and Opportunities Ahead

  Moderator

  David Heaney,

  Chief Information Security Officer, Mass General Brigham

  Speakers

  Rich Adduci,

  Operating Partner, Berkshire Partners

  Nancy Cam-Winget,

  Cisco Fellow, Cisco Systems

  Tal Liani,

  Data Networking and Networking Security Analyst, BofA Securities

  Ariel Stern, PhD,

  Alexander von Humboldt Professor, Hasso Plattner Institute

  Engy Ziedan, PhD,

  Chief Scientific Officer, Protege

• 09:10 AM - 09:50 AM

  Beyond Opioids | Existing Therapies and Innovations in Pain Management

  Moderator

  Robert Edwards, PhD,

  Clinical Psychologist, Pain Management Center, Brigham and Women’s Hospital;

  Associate Professor of Anesthesia, Harvard Medical School

  Speakers

  Roman Camarda,

  Principal, Novo Holdings Venture Investments

  Lilit Garibyan, MD, PhD,

  Physician-Scientist, Wellman Center for Photomedicine, Mass General Brigham;

  Associate Professor of Dermatology, Harvard Medical School

  Paul Negulescu, PhD,

  Senior Vice President and Disease Area Executive for Pain, Vertex

• 09:10 AM - 09:50 AM

  Xenotransplant | The Clinical Reality Emerges

  Moderator

  Leonardo Riella, MD, PhD,

  Medical Director of Kidney Transplantation, Massachusetts General Hospital;

  Harold and Ellen Danser Endowed Chair in Transplantation, Harvard Medical School

  Speakers

  Mike Curtis,

  President & CEO, eGenesis

  Pablo Legorreta,

  Founder, CEO & Chairman, Royalty Pharma

  Julie Sunderland,

  Founder & President, Oriane Consulting

• 09:10 AM - 09:50 AM

  Gene Editing | Precision Medicine in Practice

  Moderator

  Benjamin Kleinstiver, PhD,

  Investigator, Center for Genomic Medicine; Kayden-Lambert MGH Research Scholar 2023-2028, Mass General Brigham;

  Associate Professor of Pathology, Harvard Medical School

  Speakers

  Omar Abudayyeh, PhD,

  Director of Gene Editing, Gene and Cell Therapy Institute, Mass General Brigham;

  Assistant Professor of Medicine, Harvard Medical School

  Steve Favaloro,

  Chairman & CEO, Genezen

  David Liu, PhD

  Richard Merkin Professor; Director, Merkin Institute of Transformative Technologies in Healthcare, Broad Institute

  Trevor Martin, PhD,

  Co-founder & CEO, Mammoth Biosciences

  Laura Sepp-Lorenzino, PhD,

  Senior Advisor, Former CSO, Intellia Therapeutics

• 09:10 AM - 09:50 AM

  Emerging Treatments

  Emerging Treatments | Cardiovascular Disease

  Moderators

  Tazeen Ahmad,

  SMid-Cap Biotech Analyst, BofA Securities

  Tim Anderson, MD,

  Pharmaceutical Analyst, BofA Securities

  Speakers

  Brian Bergmark, MD,

  Interventional Cardiologist, Brigham and Women’s Hospital;

  Assistant Professor of Medicine, Harvard Medical School

  Erin Bohula, MD, DPhil,

  Cardiologist, TIMI Study Group, Brigham and Women’s Hospital;

  Assistant Professor of Medicine, Harvard Medical School

  Calum MacRae, MD, PhD,

  Vice Chair for Scientific Innovation, Department of Medicine, Brigham and Women's Hospital;

  Professor of Medicine, Harvard Medical School

  Pradeep Natarajan, MD,

  Director of Preventive Cardiology, Paul & Phyllis Fireman Endowed Chair in Vascular Medicine, Massachusetts General Hospital;

  Associate Professor of Medicine, Harvard Medical School